
1. Technology overview
Brainreader A/S is a Danish medtech company with offices in Aalborg, Denmark and Tampa, Florida. It provides software that helps radiologists and neurologists quantify brain structure on MRI to support diagnosis and monitoring of neurodegenerative conditions.
Neuroreader automatically quantifies 83 brain volumes from a compatible 3D T1-weighted MRI, compares them with reference data and returns a structured report. Studies are submitted through PACS or a web workflow and processed in under 10 minutes. The product is FDA-cleared and CE-marked, and targets hospitals, imaging centers and government healthcare.
2. Highlighted features & specifications
- Automated volumetry: quantifies 83 brain volumes from compatible MRI studies.
- Normative comparison: z-score and percentile comparison against reference data.
- Structured reports: color-highlighted results for physician review.
- Longitudinal tracking: charts volume change across exams relative to baseline.
- Visualisations: brain heat maps and bar charts.
- Flexible submission: supports PACS-integrated and web-based workflows.
3. Potential application
Large Vietnamese hospitals could add volumetry to memory-clinic MRI workflows. Private imaging centres could offer quantitative brain reports as a value-added service. Neurology departments could track atrophy in patients after traumatic brain injury.
4. Benefits
Gives radiologists objective brain volume measurements with z-scores and percentiles instead of visual estimation alone. Reports are ready in under 10 minutes and fit PACS-based workflows. Longitudinal charts show change from baseline across exams, supporting follow-up of dementia and brain injury patients.
5. Market trends & opportunities
Brain MRI volumetry is gaining reimbursement and regulatory support as dementia diagnosis moves earlier. Vietnam has an ageing population and growing MRI capacity in large hospitals, which creates demand for quantitative tools that assist neuroimaging reads.
6. Other information
Entities: Brainreader A/S (Aalborg, Denmark) and Brainreader Inc. (Tampa, Florida). Raised 6.6M EUR in May 2025 led by Dahlgren Capital with Investo Capital. Neuroreader is FDA-cleared (K140828) and CE-marked (per Tech.eu).
One platform connecting startups, corporations, research institutions, regions and investors











Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
RETAIL E-COMMERCE: AI AND REAL-TIME DATA ARE TRANSFORMING HOW RETAIL BUSINESSES OPERATE








































